Malaysia MDA Hologram Security Label for Medical Devices
The Malaysian Ministry of Health (MOH) and Medical Device Authority (MDA) announced the phased implementation of a Hologram Security Label for registered medical devices. The initiative aims to strengthen post-market surveillance, improve product traceability and help medical device and IVD manufacturers, healthcare professionals and consumers identify registered products and combat counterfeit and unregistered medical devices.
Malaysia’s Medical Device Authority (MDA) will progressively implement a Hologram Security Label for registered medical devices to strengthen post-market surveillance, improve product traceability and help combat counterfeit and unregistered medical devices. For medical device and IVD manufacturers, the initiative may introduce additional considerations for product labelling, packaging, inventory and supply-chain management.
Key Updates on the Hologram Security Label
The Ministry of Health Malaysia (MOH) announced the initiative on 5 August 2026, with implementation planned in phases.
The Hologram Security Label aims to:
- Help identify medical devices registered with the MDA
- Support product authenticity verification
- Improve supply-chain traceability
- Strengthen post-market surveillance
- Reduce counterfeit and unregistered medical devices
- Support regulatory enforcement
The initiative will be implemented through collaboration between the MDA, MOH and industry stakeholders.
What Does This Mean for Medical Device and IVD Manufacturers?
The new initiative could have a direct impact on manufacturers supplying products to the Malaysian market. Companies should monitor forthcoming MDA guidance on:
- Which medical devices and IVDs will be covered
- Whether existing registered products will require the hologram
- Implementation and transition timelines
- Hologram placement and verification requirements
- Impact on product labels and packaging
- Treatment of existing inventory
- Responsibilities of manufacturers, authorised representatives, importers and distributors
Manufacturers should not make changes to approved labels or packaging until the formal requirements are published.
Potential Impact on Existing Products
If existing registered products are included in the phased implementation, manufacturers may need to assess products already manufactured, in transit or held by distributors in Malaysia.
Companies should therefore maintain an up-to-date overview of their:
- Malaysian registered products
- Product and packaging configurations
- Existing inventory
- Distribution channels
This will help regulatory, quality and supply-chain teams respond efficiently once the MDA confirms the transition requirements.
Strengthening Post-Market Surveillance
The initiative builds on Malaysia’s experience with the Farmatag pharmaceutical hologram system, which has been used since 2005.
For medical devices, the Hologram Security Label is intended to provide an additional mechanism for product authentication, traceability and counterfeit detection. This supports Malaysia’s broader efforts to strengthen post-market controls and the integrity of the medical device supply chain.
Official Announcement Expected at IMDEC 2026
The Minister of Health Malaysia is expected to officially announce the implementation of the Hologram Security Label at the International Medical Device Exhibition and Conference (IMDEC) 2026 on 26 August 2026.
The announcement is expected to provide further details on the scope, timeline and responsibilities for industry stakeholders.
What Should Manufacturers Do Now?
Medical device and IVD manufacturers supplying Malaysia should:
- Monitor MDA communications for the formal implementation guidance.
- Review their Malaysian product portfolio and existing registrations.
- Assess current labelling, packaging and inventory processes.
- Prepare regulatory, quality and supply-chain teams for potential implementation changes.
Conclusion
Malaysia’s Hologram Security Label initiative represents an important development in the country’s medical device post-market regulatory framework. For manufacturers and IVD companies, understanding how the requirement will apply to existing registrations, new products, labelling, packaging and inventory will be critical.
Further details are expected following the official announcement at IMDEC 2026 on 26 August 2026.
Official link:
Suggested internal links:
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us










